AGTC - Applied Genetic Technologies Corporation
| Previous Close | 4.4400 |
| Open | 4.3600 |
| Bid | 2.1900 x 1000 |
| Ask | 5.0000 x 800 |
| Day's Range | 4.0700 - 4.3900 |
| 52 Week Range | 2.2600 - 7.5000 |
| Volume | 76,730 |
| Avg. Volume | 113,480 |
| Market Cap | 75.204M |
| Beta (3Y Monthly) | 4.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9790 |
| Earnings Date | Feb 6, 2018 - Feb 12, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.35 |
- MoneyShow•18 days ago
Applied Genetic Technologies- An Eye on Optogenetics
Applied Genetic Technologies (AGTC) is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases, explains Bill Mathews, small cap expert and editor of The Cheap Investor.
- Zacks•25 days ago
Will Applied Genetic Technologies Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor in Applied Genetic.
- Thomson Reuters StreetEvents•last month
Edited Transcript of AGTC earnings conference call or presentation 7-Feb-19 1:00pm GMT
Q2 2019 Applied Genetic Technologies Corp Earnings Call
- Associated Press•last month
Applied Genetic Technologies: Fiscal 2Q Earnings Snapshot
On a per-share basis, the Alachua, Florida-based company said it had a loss of 23 cents. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- GlobeNewswire•last month
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2018
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 07, 2019 -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of.
- Zacks•2 months ago
Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out for
Applied Genetic Technologies (AGTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire•3 months ago
New Research: Key Drivers of Growth for Hewlett Packard Enterprise, Micron Technology, Cirrus Logic, Applied Genetic Technologies, KemPharm, and Communications — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Jan. 02, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Simply Wall St.•3 months ago
Applied Genetic Technologies Corporation (NASDAQ:AGTC): Time For A Financial Health Check
The direct benefit for Applied Genetic Technologies Corporation (NASDAQ:AGTC), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. However, the Read More...
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of AGTC earnings conference call or presentation 8-Nov-18 1:00pm GMT
Q1 2019 Applied Genetic Technologies Corp Earnings Call
Zacks•3 months agoApplied Genetic Technologies Enters Oversold Territory
Applied Genetic Technologies has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
- Benzinga•3 months ago
Sell-Side Roundup: What's Next For For Applied Genetic After 50% Plunge?
Applied Genetic Technologies Corp (NASDAQ: AGTC ), a biotech focused on adeno-associated virus-based gene therapies for the treatment of rare diseases, reported disappointing results from an X-linked retinoschisis ...
- Benzinga•3 months ago
The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stock hit 52-week high in Wednesday's session. Down In The Dumps (Biotech stocks hitting 52-week lows on Dec. ...
- ACCESSWIRE•3 months ago
Today's Research Reports on Trending Tickers: Novavax and Applied Genetic Technologies
NEW YORK, NY / ACCESSWIRE / December 13, 2018 / U.S. equities closed higher on Wednesday amidst renewed hopes over the U.S.-China trade talks. According to a report in Wall Street Journal, China is working ...
- GlobeNewswire•3 months ago
AGTC Announces Topline Interim Six-Month Data from Phase 1/2 X-Linked Retinoschisis Clinical Study; Termination of Biogen Collaboration
- Results from XLRS study support general safety and tolerability of AGTC’s gene delivery platform but did not demonstrate signs of clinical activity at interim six-month time.
- GlobeNewswire•4 months ago
Consolidated Research: 2018 Summary Expectations for Tapestry, Mallinckrodt public limited company, Moxian, Applied Genetic Technologies, VistaGen Therapeutics, and Oasis Midstream Partners LP — Fundamental Analysis, Key Performance Indications
NEW YORK, Nov. 15, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Zacks•4 months ago
Applied Genetic Technologies (AGTC) Tops Q1 Earnings and Revenue Estimates
Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of 114.00% and 383.93%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•4 months ago
Applied Genetic Technologies: Fiscal 1Q Earnings Snapshot
On a per-share basis, the Alachua, Florida-based company said it had net income of 7 cents. The biotechnology company posted revenue of $14 million in the period. Applied Genetic Technologies shares have ...
- GlobeNewswire•4 months ago
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 08, 2018 -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of.
- GlobeNewswire•5 months ago
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 8, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 01, 2018 -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of.
- Zacks•5 months ago
Earnings Preview: Applied Genetic Technologies (AGTC) Q1 Earnings Expected to Decline
Applied Genetic Technologies (AGTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Benzinga•6 months ago
Wells Fargo Bullish On Applied Genetic Technologies Ahead Of Program Update
The bullish case for Applied Genetic Technologies Corp (NASDAQ: AGTC ), a nano-cap biotech conducting human clinical trials of adeno-associated virus-based gene therapies, can be made on the basis of an ...
- Thomson Reuters StreetEvents•6 months ago
Edited Transcript of AGTC earnings conference call or presentation 10-Sep-18 8:30pm GMT
Q4 2018 Applied Genetic Technologies Corp Earnings Call
- GuruFocus.com•6 months ago
Applied Genetic Technologies Corp (AGTC) Files 10-K for the Fiscal Year Ended on June 30, 2018
Warning! GuruFocus has detected 2 Warning Signs with AGTC. For the last quarter Applied Genetic Technologies Corp reported a revenue of $3.60 million, compared with the revenue of $8.39 million during the same period a year ago. The Applied Genetic Technologies Corp had an operating margin of -92.55%, compared with the operating margin of 4.82% a year before.
